title: Adverse drug reaction driven immunosuppressive drug manipulations: a single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetil.
abstract: Enteric-coated mycophenolate sodium (MPS) has been developed to help circumvent the upper gastrointestinal side-effects of mycophenolic acid by facilitating drug release in the small intestine. Many questions regarding the side-effect profile of MPS remain. Therefore, the purpose of this study is to review a single-center's experience with mycophenolate mofetil (MMF) and MPS.
  
  
  METHODS
  This retrospective, sequential cohort analysis of de novo renal and pancreas transplants (n = 198) compared MMF 500 mg b.i.d. to MPS 360 mg b.i.d. in conjunction with antibody induction, tacrolimus, and steroids.
  
  
  RESULTS
  There were fewer adverse event driven drug manipulations in the MPS group at 90 d (4% MPS vs. 17% MMF) and 180 d (10% MPS vs. 24% MMF, p = 0.006, log-rank) after transplantation. There was a trend toward fewer GI-related hospital admissions in the MPS arm (7% MPS vs. 13% MMF, p = 0.18). Allograft outcomes including patient survival, graft survival, acute rejection, serum creatinine, and infection were similar.
  
  
  CONCLUSIONS
  This single-center, sequential cohort study demonstrates that MPS is associated with fewer adverse event driven drug manipulations while maintaining similar safety and allograft outcomes.
authors.affiliation: Division of Pharmacy Practice, University of Missouri-Kansas City, Kansas City, MO, USA. hardingerk@umkc.edu
authors.forename: Karen L
authors.initials: KL
authors.lastname: Hardinger
authors.forename: Sudarshan
authors.initials: S
authors.lastname: Hebbar
authors.forename: Terry
authors.initials: T
authors.lastname: Bloomer
authors.forename: Daniel
authors.initials: D
authors.lastname: Murillo
mesh_terms: D000328:Adult; D015331:Cohort Studies; D004339:Drug Compounding; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000737:chemistry; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000737:chemistry; D016035:Pancreas Transplantation; D012189:Retrospective Studies; D013608:Tablets, Enteric-Coated
chemical_list: D007166:Immunosuppressive Agents; D013608:Tablets, Enteric-Coated; D009173:Mycophenolic Acid